510(k) Report

510(k) · Cleared

Cleared

EMPOWR Revision Symmetric Knee Cones

K240324510(k) TraditionalCleared Apr 26, 202484-day reviewClass II21 CFR 888.3560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Encore Medical, L.P. (Dba Enovis) · JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer

Cleared on Apr 26, 2024 as substantially equivalent to K200653 (Lima Corporate S.P.A., 2020) after an 84-day review. Its family tree reaches back 7 generations to 1998. 1 later device descends from it.

Decided
Apr 26, 2024
Review
84 days
Class
Class II
Product code
JWH
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K982302 (1998). 19 ancestors in all, the oldest K980781 (1998). 1 later device descends from it, 1 citing it directly.

  1. Root · 7 generations backK982302 Implex Continuum Knee - Hedrocel Tibial SpacersImplex Corp. · 1998
  2. 6 generations backK024161 Nexgen Complete Knee Solution - Trabecular Metal AugmentsImplex Corp. · 2003 · Recalled
  3. 5 generations backK040487 Trabecular Metal Knee System AugmentsImplex Corp. · 2004 · Recalled
  4. 4 generations backK053340 Trabecular Metal Tibial and Femoral Cone AugmentsZimmer Trabecular · 2006
  5. 3 generations backK100391 Depuy Universal Gription TF ConesDePuy Orthopaedics, Inc. · 2010
  6. 2 generations backK143393 Triathlon Tritanium Cone AugmentsStryker Orthopaedics · 2015 · Recalled
  7. 1 generation backK200653 AMF Revision TT ConesLima Corporate S.P.A. · 2020
  8. This deviceK240324 EMPOWR Revision Symmetric Knee ConesEncore Medical, L.P. (Dba Enovis) · 2024
  9. Descendant · cites it directly · 0 of its ownK251241 EMPOWR Revision Knee™ (EMPOWR Revision Knee™ Symmetric TT Cones)Encore Medical L.P. · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K251241EMPOWR Revision Knee™ (EMPOWR Revision Knee™ Symmetric TT Cones)Encore Medical L.P. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K982302Implex Continuum Knee - Hedrocel Tibial SpacersImplex Corp.1998—
−6K024161Nexgen Complete Knee Solution - Trabecular Metal AugmentsImplex Corp.20032
−5K040487Trabecular Metal Knee System AugmentsImplex Corp.20041
−4K053340Trabecular Metal Tibial and Femoral Cone AugmentsZimmer Trabecular2006—
−3K100391Depuy Universal Gription TF ConesDePuy Orthopaedics, Inc.2010—
−2K143393Triathlon Tritanium Cone AugmentsStryker Orthopaedics20151
−1K200653AMF Revision TT ConesLima Corporate S.P.A.2020—
0 (this device)K240324EMPOWR Revision Symmetric Knee ConesEncore Medical, L.P. (Dba Enovis)2024—
+1K251241EMPOWR Revision Knee™ (EMPOWR Revision Knee™ Symmetric TT Cones)Encore Medical L.P.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200010
200110
200310
200430
200520
200610
201010
201110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K240324, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JWH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JWH device

  1. #1 K221479 Persona Personalized Knee Systemscore 22.4 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K200653AMF Revision TT Cones
Summary page 4
…3560 / 21 CFR 888.3565 Regulatory Class: II Primary Product Code: JWH Secondary Product Code: MBH III. PREDICATE / REFERENCE DEVICES Predicate: AMF Revision TT Cones, (K200653) Reference: LINK TrabecuLink® Femoral Cones, (K201364) 3D Metal Diaphyseal Femoral Cones, (K200075) IV. DEVICE DESCR…
Lima Corporate S.P.A.2020—
†K201364LINK TrabecuLink Femoral ConesWaldemar Link GmbH & Co. KG2020—
†K2000753DMetal Diaphyseal Femoral ConesMedacta International S.A.2020—

Also cleared against K200653: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K251241EMPOWR Revision Knee™ (EMPOWR Revision Knee™ Symmetric TT Cones)Encore Medical L.P.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 6 companies; a new generation was cleared every 4.3 years on median.
  • 6 of the 19 ancestors have a recall of any class.
  • Of its descendants, K251241 (Encore Medical L.P., 2025) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K200653.

How does its category compare?

All JWH devices

JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · JWH

20in 2025

2007: 182008: 172009: 112010: 192011: 252012: 332013: 312014: 332015: 272016: 182017: 252018: 252019: 282020: 222021: 242022: 172023: 202024: 192025: 202026 (partial year): 12
2007high 33 (2012) · low 11 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JWH

55in 2025

2007: 74 days median2008: 81 days median2009: 168 days median2010: 85 days median2011: 87 days median2012: 85 days median2013: 128 days median2014: 98 days median2015: 87 days median2016: 88 days median2017: 118 days median2018: 90 days median2019: 133 days median2020: 59 days median2021: 61 days median2022: 56 days median2023: 57 days median2024: 89 days median2025: 55 days median2026 (partial year): 63 days median
2007high 168 (2009) · low 55 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JWH

2in 2025

2007: 142008: 102009: 1092010: 322011: 272012: 852013: 312014: 132015: 112016: 172017: 612018: 142019: 52020: 22021: 82022: 122023: 672024: 72025: 22026 (partial year): 4
2007high 109 (2009) · low 2 (2020)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JWH

9,306in 2025

2007: 1,3052008: 1,4832009: 1,8702010: 3,2862011: 5,1332012: 5,2032013: 6,1352014: 6,7222015: 6,8812016: 7,5862017: 12,2632018: 14,0712019: 14,9872020: 12,5922021: 9,4082022: 8,3642023: 8,9472024: 10,8282025: 9,306
2007high 14,987 (2019) · low 1,305 (2007)2025

MAUDE reports naming product code JWH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071874141,305
20081781101,483
2009111681091,870
20101985323,286
20112587275,133
20123385855,203
201331128316,135
20143398136,722
20152787116,881
20161888177,586
2017251186112,263
201825901414,071
201928133514,987
20202259212,592
2021246189,408
20221756128,364
20232057678,947
20241989710,828
2025205529,306
202612634—

What is it indicated for?

Total joint replacement is indicated for patients suffering from disability due to: -degenerative, post-traumatic or rheumatoid arthritis; -avascular necrosis of the femoral condyle; -post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy; -moderate valgus, varus or flexion deformities; This device may also be indicated in the salvage of previously failed surgical attempts where…

Read the full statement (154 words)

Total joint replacement is indicated for patients suffering from disability due to:

-degenerative, post-traumatic or rheumatoid arthritis;

-avascular necrosis of the femoral condyle;

-post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy;

-moderate valgus, varus or flexion deformities;

This device may also be indicated in the salvage of previously failed surgical attempts where bone loss may require the use of augments, sleeves cones or extensions.

The EMPOWR Revision Knee TM Symmetric Cones are indicated for the following conditions:

• EMPOWR TM Revision Knee TM Symmetric Cones are indicated for use in skeletally mature patients with bone defect or poor bone quality (osteoporotic bone) or in case of sclerotic bone that requires supplemental fixation in the clinical judgment of the surgeon.

• EMPOWR TM Revision Knee TM Symmetric Cones are indicated for uncemented fixation to the bone and are fixed to the femoral and tibial implants using bone cement.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K240324: EMPOWR Revision Symmetric Knee Cones.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K240324

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026